Literature DB >> 8613544

Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness.

O Einarsson1, G P Geba, Z Zhu, M Landry, J A Elias.   

Abstract

To address the role of IL-11 in viral airways dysfunction, we determined whether infectious agents that exacerbate asthma stimulate stromal cell IL-11 production, determined whether IL-11 could be detected at sites of viral infection and evaluated the effects of IL-11 on airway physiology. Respiratory syncytial virus (RSV), parainfluenza virus type 3 (PIV3), and rhinovirus (RV) 14 were potent stimulators while cytomegalovirus and adenovirus only weakly stimulated and herpes simplex virus type 2 and bacteria did not stimulate IL-11 elaboration. IL-11 was not detected or barely detected in nasal aspirates from children without, but was detected in aspirates from children with viral upper respiratory tract infections. The levels of IL-11 were highest in patients with clinically detectable wheezing. IL-11 also caused nonspecific airways hyperresponsiveness in BALB/c mice. These studies demonstrate that three major causes of viral-induced asthma, RSV, RV, and PIV, in contrast to other viruses and bacteria, share the ability to induce stromal cell IL-11 production. They also demonstrate that IL-11 can be detected in vivo during viral respiratory infections, that the presence of IL-11 correlates with clinical bronchospasm and that IL-11 is a potent inducer of airways hyperresponsiveness. IL-11 may be an important mediator in viral airways disorders.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613544      PMCID: PMC507136          DOI: 10.1172/JCI118514

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  An economic evaluation of asthma in the United States.

Authors:  K B Weiss; P J Gergen; T A Hodgson
Journal:  N Engl J Med       Date:  1992-03-26       Impact factor: 91.245

Review 2.  Acute lower respiratory tract infections in nonhospitalized children.

Authors:  F W Denny; W A Clyde
Journal:  J Pediatr       Date:  1986-05       Impact factor: 4.406

3.  Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates.

Authors:  R H Gundel; L G Letts; G J Gleich
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

Review 4.  Respiratory infections and asthma.

Authors:  U S Björnsdottir; W W Busse
Journal:  Med Clin North Am       Date:  1992-07       Impact factor: 5.456

5.  Airway epithelial cell expression of interleukin-6 in transgenic mice. Uncoupling of airway inflammation and bronchial hyperreactivity.

Authors:  B F DiCosmo; G P Geba; D Picarella; J A Elias; J A Rankin; B R Stripp; J A Whitsett; R A Flavell
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

6.  Lack of a role of interleukin 11 in the growth of multiple myeloma.

Authors:  S R Paul; B A Barut; F Bennett; M A Cochran; K C Anderson
Journal:  Leuk Res       Date:  1992       Impact factor: 3.156

7.  Cytokines contribute to airway dysfunction in antigen-challenged guinea pigs: inhibition of airway hyperreactivity, pulmonary eosinophil accumulation, and tumor necrosis factor generation by pretreatment with an interleukin-1 receptor antagonist.

Authors:  M L Watson; D Smith; A D Bourne; R C Thompson; J Westwick
Journal:  Am J Respir Cell Mol Biol       Date:  1993-04       Impact factor: 6.914

8.  Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs.

Authors:  A J Van Oosterhout; A R Ladenius; H F Savelkoul; I Van Ark; K C Delsman; F P Nijkamp
Journal:  Am Rev Respir Dis       Date:  1993-03

9.  Pulmonary responses to bronchoconstrictor agonists in the mouse.

Authors:  T R Martin; N P Gerard; S J Galli; J M Drazen
Journal:  J Appl Physiol (1985)       Date:  1988-06

Review 10.  Viruses as precipitants of asthma symptoms. I. Epidemiology.

Authors:  P K Pattemore; S L Johnston; P G Bardin
Journal:  Clin Exp Allergy       Date:  1992-03       Impact factor: 5.018

View more
  57 in total

1.  Human major group rhinoviruses downmodulate the accessory function of monocytes by inducing IL-10.

Authors:  J Stöckl; H Vetr; O Majdic; G Zlabinger; E Kuechler; W Knapp
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

Review 2.  Airway remodeling in asthma.

Authors:  J A Elias; Z Zhu; G Chupp; R J Homer
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

Review 3.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

4.  Human rhinovirus attenuates the type I interferon response by disrupting activation of interferon regulatory factor 3.

Authors:  Tao Peng; Swathi Kotla; Roger E Bumgarner; Kurt E Gustin
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

Review 5.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

Review 6.  Mechanisms of virus induced exacerbations of asthma.

Authors:  J M Corne; S T Holgate
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 7.  Neurology of allergic inflammation and rhinitis.

Authors:  Brendan J Canning
Journal:  Curr Allergy Asthma Rep       Date:  2002-05       Impact factor: 4.806

8.  Persistent activation of RelA by respiratory syncytial virus involves protein kinase C, underphosphorylated IkappaBbeta, and sequestration of protein phosphatase 2A by the viral phosphoprotein.

Authors:  V Bitko; S Barik
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

Review 9.  Association of rhinovirus infections with asthma.

Authors:  J E Gern; W W Busse
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

10.  Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and -independent phenotypes.

Authors:  P Ray; W Tang; P Wang; R Homer; C Kuhn; R A Flavell; J A Elias
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.